423 related articles for article (PubMed ID: 9737846)
1. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?
Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Sep; 37(37):12700-6. PubMed ID: 9737846
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
[TBL] [Abstract][Full Text] [Related]
3. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
[TBL] [Abstract][Full Text] [Related]
4. Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters.
Ikebe J; Kamiya N; Ito J; Shindo H; Higo J
Protein Sci; 2007 Aug; 16(8):1596-608. PubMed ID: 17656579
[TBL] [Abstract][Full Text] [Related]
5. Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F).
Poulsen SA; Watson AA; Fairlie DP; Craik DJ
J Struct Biol; 2000 Jun; 130(2-3):142-52. PubMed ID: 10940222
[TBL] [Abstract][Full Text] [Related]
6. Structure of amyloid beta fragments in aqueous environments.
Takano K; Endo S; Mukaiyama A; Chon H; Matsumura H; Koga Y; Kanaya S
FEBS J; 2006 Jan; 273(1):150-8. PubMed ID: 16367755
[TBL] [Abstract][Full Text] [Related]
7. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
Narayanan S; Kamps B; Boelens WC; Reif B
FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
[TBL] [Abstract][Full Text] [Related]
8. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
Narayanan S; Reif B
Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
[TBL] [Abstract][Full Text] [Related]
9. Effect of D-amino acids at Asp23 and Ser26 residues on the conformational preference of Abeta20-29 peptides.
Shanmugam G; Polavarapu PL; Hallgas B; Majer Z
Biochem Biophys Res Commun; 2005 Sep; 335(3):712-22. PubMed ID: 16091285
[TBL] [Abstract][Full Text] [Related]
10. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
11. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
Dong X; Chen W; Mousseau N; Derreumaux P
J Chem Phys; 2008 Mar; 128(12):125108. PubMed ID: 18376983
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment.
Kohno T; Kobayashi K; Maeda T; Sato K; Takashima A
Biochemistry; 1996 Dec; 35(50):16094-104. PubMed ID: 8973180
[TBL] [Abstract][Full Text] [Related]
13. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
[TBL] [Abstract][Full Text] [Related]
15. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of amyloid beta-peptide (25-35) in different media.
D'Ursi AM; Armenante MR; Guerrini R; Salvadori S; Sorrentino G; Picone D
J Med Chem; 2004 Aug; 47(17):4231-8. PubMed ID: 15293994
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.
Whittemore NA; Mishra R; Kheterpal I; Williams AD; Wetzel R; Serpersu EH
Biochemistry; 2005 Mar; 44(11):4434-41. PubMed ID: 15766273
[TBL] [Abstract][Full Text] [Related]
18. Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques.
Rodziewicz-Motowidło S; Juszczyk P; Kołodziejczyk AS; Sikorska E; Skwierawska A; Oleszczuk M; Grzonka Z
Biopolymers; 2007 Sep; 87(1):23-39. PubMed ID: 17534931
[TBL] [Abstract][Full Text] [Related]
19. Secondary structure conversions of Alzheimer's Abeta(1-40) peptide induced by membrane-mimicking detergents.
Wahlström A; Hugonin L; Perálvarez-Marín A; Jarvet J; Gräslund A
FEBS J; 2008 Oct; 275(20):5117-28. PubMed ID: 18786140
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.
Terzi E; Hölzemann G; Seelig J
Biochemistry; 1997 Dec; 36(48):14845-52. PubMed ID: 9398206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
